Press Releases

Calixar SAS, a start-up providing services focused on membrane proteins, announces today that it has completed an initial funding round in which it raised EUR 875,000 from private investors and business angels. The investors that...

Alexion Pharmaceuticals today announced the presentation of data that underscore the critical need for testing patients at high risk for paroxysmal nocturnal hemoglobinuria (PNH) and new data on the potentially life-threatening, systemic complications in patients with atypical hemolytic uremic...

The recently formed strategic, transactional and operational advisory firm, Alliance4Growth (A4G), is pleased to announce its participation to the BIO US conference, a premier venue in the Life Sciences and Biotechnology arenas, in support to its endeavors with...

Adocia , a biotechnology company specialized in the development of best-in-class medicines with already-approved therapeutic proteins, announces that the USPTO  and the EPO have issued a patent covering BioChaperone PDGF formulations for chronic wound treatment, including diabetic foot ulcer, to...

Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for aggregating and structuring biomedical data with intuitive...

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the appointment of Christine Placet as chief executive officer, effective immediately. ...

Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the appointment of Damian Marron as chief executive officer. Damian was previously CEO at Trophos SA. The first task...